RT Conference Proceedings
T1 RESILIENT part 1: Pharmacokinetics of second-line (2L) liposomal irinotecan in patients with small cell lung cancer (SCLC)
A1 Ponce, S.
A1 Brendel, K.
A1 Spigel, D. R.
A1 Chen, Y.
A1 Jove Casulleras, M.
A1 Juan-Vidal, O.
A1 Rich, P.
A1 Hayes, T.
A1 Gutierrez Calderon, V.
A1 Bernabe Caro, R.
A1 Navarro, A.
A1 Dowlati, A.
A1 Zhang, B.
A1 Moore, Y.
A1 Kokhreidze, J.
A1 Pedret-Dunn, A.
A1 Paz-Ares, L.
A1 Bunn, P. A.
PB Elsevier
SN 0923-7534
YR 2020
FD 2020-09-01
LK https://hdl.handle.net/10668/24579
UL https://hdl.handle.net/10668/24579
LA en
DS RISalud
RD Apr 8, 2025